Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localised Prostate Cancer”

556 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 556 results

Post-approval studies (Phase 4)Ended earlyNCT01512472
What this trial is testing

Firmagon (Degarelix) Intermittent Therapy

Who this might be right for
Prostate Cancer Recurrent
Canadian Urology Research Consortium 144
Not applicableActive Not RecruitingNCT03234556
What this trial is testing

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Who this might be right for
Health Status UnknownElevated PSA
University of Southern California 288
Not applicableNot Yet RecruitingNCT07040501
What this trial is testing

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)UnknownNCT02037464
What this trial is testing

CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 100
Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Not applicableUnknownNCT01177865
What this trial is testing

Study of Treatment Choice in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 432
Not applicableStudy completedNCT04484246
What this trial is testing

Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Assistance Publique Hopitaux De Marseille 112
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT00126165
What this trial is testing

Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alberta Health services 72
Not applicableNot Yet RecruitingNCT06945172
What this trial is testing

Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

Who this might be right for
Prostate Cancer
GCS Ramsay Santé pour l'Enseignement et la Recherche 102
Not applicableLooking for participantsNCT06027892
What this trial is testing

Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

Who this might be right for
PROSTATE CANCER
Rabin Medical Center 562
Testing effectiveness (Phase 2)Study completedNCT02095145
What this trial is testing

Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
PSA Level Less Than or Equal to FifteenPSA Level Less Than TenStage I Prostate Cancer AJCC v7+3 more
National Cancer Institute (NCI) 38
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Large-scale testing (Phase 3)UnknownNCT02934685
What this trial is testing

IG-VMAT for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Beijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00913263
What this trial is testing

An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

Who this might be right for
Prostate Cancer
Lidds AB 24
Testing effectiveness (Phase 2)Study completedNCT01620515
What this trial is testing

Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

Who this might be right for
Prostate Cancer
Nymox Corporation 141
Not applicableStudy completedNCT01714219
What this trial is testing

Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy

Who this might be right for
Localized Prostate CancerUrinary Incontinence
Seoul National University Hospital 100
Load More Results